Strategic Versatility regularly produces content on the latest U.S. regulatory and enforcement activities that impact life sciences organizations. And not just a bland rundown of what happened, but practical tools so you can ensure you are appropriately evolving your compliance program.
Our flagship SV Publications offerings include:
Subscribers also enjoy regular updates on what life sciences companiesβ Boards of Directors want to know from Compliance Officers, peer benchmarking, and ad hoc publications on evolving healthcare compliance topics (for example, risks with new commercial and medical fieldβbased roles, complianceβs role in the AI evolution, and clinical trial compliance considerations).
Rich content curated just for life sciences compliance personnel and their boards, delivered right to your inbox, with 24/7 digital and searchable access to our entire archive of publications via the subscriber website.
We offer multiple tiers of subscription services, allowing you to select which package is right for you.
Please click below and we will provide you more information on options that fit your need.

"The Compliance Debrief" is Strategic Versatility's flagship publication. Now in its 5th year, this publication has become the cornerstone of our subscription service.

New for 2026, "The Compliance Committee Briefing" is written for Compliance and Audit Committee members who need a focused quarterly lens on DOJ, FDA, OIG, SEC, and state activity. Each 6β8 page issue pulls out six developments with clear board implications and offers governanceβlevel questions for use in committee mee